Skip to content

Function of Implanted Glucose Sensor 2

Function of Implanted Glucose Sensor 2

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02345967
Acronym
FIGS-2
Enrollment
20
Registered
2015-01-26
Start date
2015-01-31
Completion date
2018-05-30
Last updated
2018-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

diabetes mellitus requiring insulin

Brief summary

The purpose of this study is to verify safety and assess tolerance of a long-term, implanted glucose monitoring sensor. The study will also provide data to characterize the response properties and calibration of the implanted sensor and determine if such properties vary with implant duration.

Interventions

DEVICEModel 100 Sensor

One Model 100 Sensor to be implanted per subject.

Sponsors

Profil Institute for Clinical Research, Inc.
CollaboratorOTHER
AMCR Institute
CollaboratorOTHER
GlySens Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Either: (1) male or (2) female and not pregnant, breastfeeding, or planning to become pregnant * Diabetes diagnosis of type 1, or type 2 using insulin * Under the routine care of a physician for diabetes treatment * Able to understand and follow directions * History of compliance with diabetes care regimen * Able to comply with study requirements regarding planned clinical visits and exams * In good physical condition without major medical concerns or blood chemistry abnormalities

Exclusion criteria

* Mental disorders that might affect compliance to protocols * Diabetes diagnosis type 2 where treatment involves (1) oral medication without insulin or (2) insulin use restricted to a single daily injection of long-acting insulin or (3) control by diet/exercise regimen alone * History of intolerance or sensitivity to any of the device materials * History of any adverse reaction or allergy to any of the drugs/agents utilized in the study procedures * History of recurrent skin infections

Design outcomes

Primary

MeasureTime frameDescription
Number of Adverse EventsFrom enrollment to 2-weeks post-explantIncidence of adverse events related to the Intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026